• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Agilent Technologies

Agilent Technologies

Agilent Technologies Inc A 3 Star

Last Price$56.84Day Change (%)-1.10%
Open Price$57.60Day Change ($)-0.63
Day Range56.71–57.7452-Week Range44.66–61.22

As of Thu 07/24/2014 05:15 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Research and Markets: New Born Screening Market Report 2014: Test Type, Technology, Instrument, Accessories, Reagent & Assay Kit Analysis

    Research and Markets: New Born Screening Market Report 2014: Test Type, Technology, Instrument, Accessories, Reagent & Assay Kit Analysis

  2. 2nd Annual Dave & Dan Classic Raises $408,000 for Credit Unions for Kids Benefiting the Children’s Miracle Network Hospitals

    2nd Annual Dave & Dan Classic Raises $408,000 for Credit Unions for Kids Benefiting the Children’s Miracle Network Hospitals

  3. Teradyne Introduces Next Generation UltraFLEX Wireless Test Solution

    Teradyne Introduces Next Generation UltraFLEX Wireless Test Solution

  4. TowerJazz Announces its 2014 Global Symposium (TGS) Roadmap focused on Expanded Technology Offerings and Increased Manufacturing Capacity

    TowerJazz Announces its 2014 Global Symposium (TGS) Roadmap focused on Expanded Technology Offerings and Increased Manufacturing Capacity

  5. Research and Markets: Global Next-generation Sequencing Market

    Research and Markets: Global Next-generation Sequencing Market

  6. Middle East/Africa: Regional Economic Review – 3Q 2013

    Agilent A reported full-year results indicating respectable revenue growth and continued improvements to profitability. We've updated our model to reflect fiscal 2006 results and are maintaining our fair value estimate. Revenues in the bio-analytical division grew 9% over last year, matching our ...

  7. What's the Best Way to Play a Large-Growth Rally?

    You'll be surprised at which funds are poised for a large-growth rebound.

  8. What the NHL Playoffs Can Teach Investors

    Agilent's A third-quarter gross margin was well ahead of our expectations for the quarter, and the company produced another respectable performance in year-over-year sales (15%) and order (11%) growth. The gross margin finished at 55%, much higher than our assumption for the quarter and 5 ...

  9. Selected American Shares Annual Review 2014

    This report includes candid statements and observations regarding investment strategies, individual securities, and economic and market conditions; however, there is no guarantee that these statements, opinions or forecasts will prove to be correct. Equity markets are volatile and an investor may ...

  10. Semiconductor Industry Outlook – April 2011

    The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.